CHU UCL Namur

Academic/Hospital

Also known as: CHU-UCL Namur (site Mont-Godinne), Belgium | Clinique Ste Elisabeth - Namur - Belgium | Clinique Ste Elisabeth, Namur, Belgium | UCL Namur

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2003

Last known activity

Jul 26, 2017

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 3 trials)

Phase 2 (8 own, 0 via acquisition)

prednisone
doxorubicin
entospletinib
epirubicin
vitamin c
vincristine
cyclophosphamide
rituximab

Indications

Studied for

Breast Neoplasms
Lymphoma, Large B-Cell, Diffuse

Recent trials (3)

NCT03225924Overall official - principal investigatorPhase 1/Phase 2Jul 26, 2017
NCT03175341CollaboratorPhase 1/Phase 2Jun 5, 2017
NCT00162812CollaboratorPhase 2Jan 1, 2003

Details

Last known activity: Jul 26, 2017